Suraksha Diagnostic Ltd. (NSE: SURAKSHA) is an Indian healthcare company that operates a wide network of diagnostic centers offering integrated pathology, radiology, and medical consultation services. Established in 1992 in Kolkata, it has grown to become one of the prominent diagnostic service providers in eastern and north-eastern India, with numerous diagnostic centers, sample collection points and a central reference laboratory accredited by the College of American Pathologists (CAP) and other quality bodies like NABL.<\/p>\n\n\n\n
The company provides a comprehensive range of tests and imaging services supported by advanced technology and expert medical professionals, and also offers convenience features such as online booking and home sample collection. Suraksha Diagnostic converted into a public limited company in 2024 and is publicly listed on Indian stock exchanges, reflecting its expanding scale and institutional growth.<\/p>\n\n\n\n
During the third quarter of FY26, the company reported total income of \u20b9783.09 million, representing a 30.3% year-on-year increase compared to Q3 FY25. EBITDA rose to \u20b9237.82 million, marking a 26.1% YoY growth, while the EBITDA margin stood at 30.6%, slightly lower than the previous year. Profit after tax (PAT) increased by 21.0% YoY to \u20b972.41 million, with the PAT margin at 9.3%. Earnings per share (EPS) for the quarter were \u20b91.44, compared with \u20b90.26 in the corresponding period last year.<\/p>\n\n\n\n
For the first nine months of FY26, total income grew 21.8% YoY to \u20b92,313.81 million, up from \u20b91,900.27 million in 9M FY25. EBITDA increased 12.8% YoY to \u20b9734.04 million, with an EBITDA margin of 31.7%, compared to 32.1% in the previous year. PAT rose 6.0% YoY to \u20b9252.43 million, while the PAT margin moderated to 10.1% from 11.0% in 9M FY25.<\/p>\n\n\n\n
Operationally, total tests conducted increased 30.7% YoY to 2.06 million in Q3 FY26, while total patients grew 23.0% YoY to 0.36 million. Tests per patient improved to 5.77, reflecting a 6.2% YoY increase. Average revenue per test remained stable at \u20b9378, broadly unchanged year-on-year.<\/p>\n\n\n\n
For the nine-month period, total tests rose 27.2% YoY to 6.18 million, and total patients increased 19.3% YoY to 1.07 million. Tests per patient increased 6.7% YoY to 5.78, indicating higher engagement per patient. However, average revenue per test declined 3.8% YoY to \u20b9370, reflecting pricing or mix changes over the period.<\/p>\n\n\n\n
The management stated that the company continued to deliver strong top-line growth in Q3 FY26, driven by robust network expansion. It explained that the temporary impact on EBITDA margins was due to the launch and development of new centers, while centers older than two years continued to operate at a healthy 37% EBITDA margin, underscoring the strength of the business model. The management emphasized that it was investing for scale, accepting short-term margin compression to achieve long-term market leadership. <\/p>\n\n\n\n
It further reported that during 9M FY26, the company added 12 fully operational centers and had six centers under development. The management added that the launch of Suraksha Sutra, its genomics and molecular diagnostics vertical, marked a successful entry into the high-value genomics segment and provided a strong first-mover advantage in Eastern India. Finally, it reaffirmed its commitment to creating shareholder value through innovation, operational excellence, and sustainable long-term growth.<\/p>\n","protected":false},"excerpt":{"rendered":"
About Suraksha Diagnostic Ltd. Suraksha Diagnostic Ltd. (NSE: SURAKSHA) is an Indian healthcare company that operates a wide network of diagnostic centers offering integrated pathology, radiology, and medical consultation services. Established in 1992 in Kolkata, it has grown to become one of the prominent diagnostic service providers in eastern and north-eastern India, with numerous diagnostic […]<\/p>\n","protected":false},"author":2389,"featured_media":125416,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[5747,1941],"tags":[13743,15890,15889],"class_list":["post-179822","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare-stocks","category-stock-analysis","tag-health-care","tag-suraksha","tag-suraksha-diagnostic-ltd"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":175965,"url":"https:\/\/alphastreet.com\/india\/suraksha-diagnostic-ltd-suraksha-q1-2026-earnings-call-transcript\/","url_meta":{"origin":179822,"position":0},"title":"Suraksha Diagnostic Ltd (SURAKSHA) Q1 2026 Earnings Call Transcript","author":"News desk","date":"January 22, 2026","format":false,"excerpt":"Suraksha Diagnostic Ltd (NSE: SURAKSHA) Q1 2026 Earnings Call dated Aug. 11, 2025 Corporate Participants: Unidentified Speaker Somnath Chatterjee \u2014 Chairman and Joint Managing Director Ritu Mittal \u2014 Joint Managing Director and Chief Executive Officer Ravindra K S \u2014 Group Chief Financial Officer Balgopal Jhunjhunwala \u2014 Regional Business Head Analysts:\u2026","rel":"","context":"In "Earnings Call Transcripts"","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":180504,"url":"https:\/\/alphastreet.com\/india\/suraksha-diagnostic-ltd-suraksha-q3-2026-earnings-call-transcript\/","url_meta":{"origin":179822,"position":1},"title":"Suraksha Diagnostic Ltd (SURAKSHA) Q3 2026 Earnings Call Transcript","author":"News desk","date":"February 12, 2026","format":false,"excerpt":"Suraksha Diagnostic Ltd (NSE: SURAKSHA) Q3 2026 Earnings Call dated Feb. 06, 2026 Corporate Participants: Unidentified Speaker Dr. Somnath Chatterjee \u2014 Chairman and Joint Managing Director Ms. Ritu Mittal \u2014 Joint Managing Director and Chief Executive Officer Ravindra K S \u2014 Chief Financial Officer NIREN KAUL \u2014 CHIEF SALES OFFICER\u2026","rel":"","context":"In "Earnings Call Transcripts"","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":175967,"url":"https:\/\/alphastreet.com\/india\/suraksha-diagnostic-ltd-suraksha-q4-2025-earnings-call-transcript\/","url_meta":{"origin":179822,"position":2},"title":"Suraksha Diagnostic Ltd (SURAKSHA) Q4 2025 Earnings Call Transcript","author":"News desk","date":"January 22, 2026","format":false,"excerpt":"Suraksha Diagnostic Ltd (NSE: SURAKSHA) Q4 2025 Earnings Call dated May. 30, 2025 Corporate Participants: Somnath Chatterjee \u2014 Chairman & Joint Managing Director Ritu Mittal \u2014 Managing Director & Chief Executive Officer Ravindra K.S. \u2014 Chief Financial Officer Analysts: Ashish Tendulkar \u2014 Analyst Preeti Agarwal \u2014 Analyst Deepak Malik \u2014\u2026","rel":"","context":"In "Earnings Call Transcripts"","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":167763,"url":"https:\/\/alphastreet.com\/india\/vijaya-diagnostic-centre-ltd-q3fy25-35-rise-in-profits\/","url_meta":{"origin":179822,"position":3},"title":"Vijaya Diagnostic Centre Ltd Q3FY25; 35% rise in Profits","author":"Chirag Gupta","date":"April 4, 2025","format":false,"excerpt":"Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories. Financial Results: Vijaya Diagnostic\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/2-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/2-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/2-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/2-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/2-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/2-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152152,"url":"https:\/\/alphastreet.com\/india\/vijaya-diagnostic-centre-ltd-q1fy24-44-rise-in-profits\/","url_meta":{"origin":179822,"position":4},"title":"Vijaya Diagnostic Centre Ltd Q1FY24; 44% rise in Profits","author":"Chirag Gupta","date":"August 9, 2023","format":false,"excerpt":"Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories. Financial Results: Vijaya Diagnostic\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-492.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-492.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-492.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-492.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-492.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-492.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":160979,"url":"https:\/\/alphastreet.com\/india\/vijaya-diagnostic-centre-ltd-q4fy24-21-rise-in-profits\/","url_meta":{"origin":179822,"position":5},"title":"Vijaya Diagnostic Centre Ltd Q4FY24; 21% rise in Profits","author":"Chirag Gupta","date":"May 9, 2024","format":false,"excerpt":"Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories. Financial Results: Vijaya Diagnostic\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-63.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-63.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-63.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-63.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-63.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-63.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/2389"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=179822"}],"version-history":[{"count":1,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179822\/revisions"}],"predecessor-version":[{"id":179823,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179822\/revisions\/179823"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/125416"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=179822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=179822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=179822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}